Academic CentreHORIZON 2020
HORIZON 2020 - combines various EU research and innovation funding instruments into a single program. More than ever, the program aims to turn scientific discoveries into innovative products and services that create new business opportunities and improve people's lives. Horizon 2020 stimulates the economy, strengthens the EU's science and technology base and industrial competitiveness in the future, towards a smarter, more sustainable and inclusive society. Thanks to it, more breakthroughs, discoveries and unique experiences will be achieved by bringing to life the great ideas of the market.
Aim: To develop a patch (sticker) for skin that incorporates sensors and is designed to detect active tuberculosis.
Duration: 01/01/2019 - 01/01/2022
Identification No.: 824270
Total funding: 484 375 EUR
Scientific manager: Dr. med. Mārcis Leja
More information on project website
Aim: To put into practice a renewed European Code of Conduct for Research Integrity, developing an innovative training program for scientists and training materials for training programs.
Duration: 01/06/2018 - 30/11/2021
Identification No.: 787580
Total funding: 74 090 EUR
Scientific manager: Dr.sc.soc. Signe Mežinska
More information on project website
Aim: This cross-sectional, laboratory-based study is aimed at evaluating and optimizing the FIND/Cepheid Xpert prototype assay for TB and rifampicin resistance detection with regard to operational applicability and clinical performance.
Duration: 01/12/2017 - 30/05/2020
Identification No.: 768889
Total funding: 307 617 EUR
Scientific manager: Ģirts Šķenders
More information in project summary
Aim: To look for new diseases and high-risk states by detecting volatile substances in exhaled air.
Duration: 15/02/2015 - 14/02/2019
Identification No.: 644031
Total funding: 599 250 EUR
Scientific manager: Dr. med. Mārcis Leja
More information on project website
Aim: To organize and attend a seminar at Tübingen University and prepare a future project for the EU framework program Horizon 2020. The further aim of the project will be to develop a tool for systematically ethical analysis of adiposity prevention measures.
Duration: 15/06/2017 - 15/10/2017
Identification No.: ZD2017/20403
Scientific manager: Dr.sc.soc. Signe Mežinska
Aim: To develop and validate a new, non-invasive, easy-to-use and cost-effective method for screening and early diagnosis of gastric and colorectal cancer and pre-cancerous conditions.
Duration: 01/07/2014 - 30/06/2017
Identification No.: ZD2014/2914
Scientific manager: Dr. med. Mārcis Leja
More information in project summary
Aim: To combine the expertise of its partners to develop an innovative platform that will support the decision-making of medical doctors to improve the care of cancer survivors.
Duration: 27/11/2019 - 28/02/2023
Identification No.: 875406
Total funding: 215 875 EUR
Scientific manager: Dr. med. Mārcis Leja
More infromation on project website
Aim: The main goal of the VOGAS project is to provide "conceptual proof" that a combination of mathematical signals generated by exhaled air from new sensors can identify gastric cancer and precancerous lesions. Another important goal of the VOGAS project is to generate new knowledge about the origin, mechanisms and applications of VOCs (volatile organic compounds) that could potentially serve for gastric cancer screening by analyzing exhaled air.
Duration: 01/01/2019 - 31/12/2021
Identification No.: 824986
Total funding: 51 000 EUR
Scientific manager: Dr. med. Mārcis Leja
More information on project website
European Regional Development Fund
ERDF - European Regional Development Fund is one of the European Structural and Investment Funds contributing to smart, sustainable and inclusive growth and aims to strengthen economic, social and territorial cohesion in the EU's regions and cities. The ERDF was established in 1975 to redress regional disparities within the Community. Under this fund, assistance is provided to less developed regions, focusing mainly on improving public infrastructure and promoting business.
Aim: To reduce the mortality caused by gastric cancer by eradicating H. pylori and determining pepsinogen levels. The GISTAR study is funded by the ERDF (European Regional Development Fund) 1.1.1.1. project "Practical Studies", 2nd phase, project ID Nr. 1.1.1.1/18/A/184
Duration: 01/04/2019 - 21/03/2022
Identification No.: 1.1.1.1/18/A/184
Total funding: 648 648 EUR
Scientific manager: Dr. med. Mārcis Leja
More information on project website
Aim: To develop a portable express breath analyzer for gastric cancer screening to determine stomach cancer and pre-cancerous conditions using nanosensor technology that determines breathing organic compounds. The project is carried out by the European Regional Development Fund (ERDF) 1.2.1.2. Measure "Support for Improvement of Technology Transfer System".
Duration: 01/02/2018 - 28/09/2021
Identification No.: KC-PI-2017/75
Total funding: 300 000, 00 EUR
Scientific manager: Dr. med. Mārcis Leja
Aim: To develop a taxonomy-based classification approach to the analysis and discovery of medical and biological data, which will serve as a way to effectively analyze large amounts of medical data. The project is funded by the ERDF (European Regional Development Fund) within the framework of the measure 1.1.1.2. "Postdoctoral Research Support" Round 2 ", Project ID Nr.1.1.1.2/VIAA/2/18/270.
Duration: 18/12/2018 - 31/12/2021
Identification No.: 1.1.1.2/VIAA/2/18/270
Total funding: 133 805,88 EUR
Scientific manager: Dr.sc.ing. Inese Poļaka
More information on project website
Project co-finansing: The project is co-financed by the European Regional Development Fund Operational Program "Growth and Jobs" 1.2.1. Specific objective 1.2.1.1 of the Specific objective "Increase private sector investment in R&D". the measure "Support for the development of new products and technologies within centers of competence".
Duration: 30/01/2020 - 31/12/2020
Identification No.: SL/1.5/2019
Total funding: 30 000 EUR
Scientific manager: Dr. med. Mārcis Leja
Aim: Within the scope of industrial research, to evaluate the long term effects of H.pylori eradication on GIT microbiome, asses its effects on abundance and prevalence of extended-spectrum b-lactamases coding genes and develop cost effective ESBL screening test prototype. The results acquired through the implementation of this Project shall provide us with enhanced understanding on long term effects of antimicrobial agents on GIT microbiome and development of antibiotic resistance. They shall also contribute to development of National eradication treatment strategy. The project is non-economic and is in line with the Biotechnology industry. It will be implemented in the "Latvian Biomedical Research and Study Center" and "University of Latvia". The project is carried out under the European Regional Development Fund (ERDF), Measure 1.1.1.1 “Industry-Driven Research”.
Duration: 01/03/2017 - 29/02/2020
Identification No.: 1.1.1.1/16/A/272
Total funding: 648 648, 00 EUR
Scientific manager: Dr. biol. D. Fridmanis
Collaboration: Latvijas Biomedicīnas pētījumu un studiju centrs
More information on project website
Aim: Investigation of volatile compounds caused by gastric microbiome, effects of microbiome changes and exhalation markers for early detection of gastric cancer. The project is funded by the ERDF (European Regional Development Fund) within the framework of the measure 1.1.1.2. "Postdoctoral Research Support" Round 3 ", Project ID Nr.1.1.1.2/VIAA/3/19/495.
Duration: 01/05/2020 - 31/04/2023
Identification No.: 1.1.1.2/VIAA/3/19/495
Total funding: 133 805,88 EUR
Scientific manager: PhD Manohar Prasad Bhandari
More information on project website
Īstenošanas periods: 01.07.2021.–30.11.2023.
Identifikācijas Nr.: 1.1.1.1/20/A/035.
Kopējais finansējums: 540 540 EUR
Zinātniskais vadītājs: Dr. med. Mārcis Leja
Vairāk informācijas skatīt projekta kopsavilkumā
UNIVERSITY OF LATVIA
UL Effective cooperation project, in cooperation with SIA AHL.
Duration: 05/09/2019 - 30/08/2021
Identification No.: 6012-A53/65
Total funding: 140 000 EUR
Scientific manager: Prof. Sergejs Isajevs
UL Effective cooperation project, in cooperation with SIA AHL.
Duration: 24/07/2017 - 30/06/2019
Identification No.: ZD2017/20444
Total funding: 140 000 EUR
Scientific manager: Prof. Sergejs Isajevs
(Sub-project of "Research of biomarkers and natural substances for acute and chronic diseases' diagnostics and personalized treatment" project)
The ultimate aim: To ensure the leading and coordinating role of the University of Latvia in the international research consortium for the prevention of gastrointestinal tumors in Europe.
Specific aim: To develop the competence and capacity of researchers of the University of Latvia in biomarker research in oncology, infectious diseases (including sepsis, tuberculosis), preventive medicine (including the GISTAR population survey). Realization of the project is closely connected with academic work (diploma papers, master's thesis, doctoral thesis), as well as other studies, including the National Research Program Biomedicine 2014-2017, the H2020 Project Sniffphone, etc. As a result of project realization, additional project application and funding attraction is expected, as well as increasing the visibility and expanding cooperation of the University of Latvia. The successful continuation of projects that have already been launched, such as the GISTAR project, will be promoted.
Duration: 01/01/2016 - 31/12/2018
Manager: Dr.habil.med. Ingrīda Rumba-Rozenfelde
Sub-project Manager: Dr.med. prof. Mārcis Leja
Specific aim: To develop cooperation within international projects, to increase the research capacity of the University of Latvia in the field of prevention of gastrointestinal tumors, to attract additional international projects for the implementation of activities in Latvia. Project activities are planned by developing cooperation with internationally recognized research centers and international organizations in the field of project application, as well as with research organizations in former Soviet countries. At the same time, the development of cooperation with merchants is foreseen. In addition to developing co-operation, it is planned to strengthen the recognition of the University of Latvia's research groups in the international space through the registration of projects implemented by KPMI in international databases (such as ClinicalTrials.gov). As a result of the project implementation, the preparation and submission of international project applications, the conclusion of co-operation agreements with research organizations and merchants are foreseen. The organization of an international workshop in Riga, as well as exchange visits, according to the available means, is foreseen to achieve the goals. The project involves leading researchers, researchers, young scientists, doctoral students of the University of Latvia. In particular, it is intended to attract expert with international experience in epidemiological issues. In addition to the contribution of the University of Latvia, it is planned to attract additional funds from international partners.
Duration: 01/01/2017 - 31/12/2017
Project manager: Dr.med., profesors Mārcis Leja
State research programs
VPP - State research programs in accordance with Section 35, Paragraph 1 of the Law on Scientific Activity of May 19, 2005 are a state order for conducting scientific research in a certain economic, educational, cultural or other state priority sector with the aim to promote the development of this sector.
Aim: To identify socio-demographic, clinical, biochemical, molecular and immunological factors caused by SARS-CoV-2 infection, which affect susceptibility to the virus, the course and outcome of the disease, and to improve the effectiveness of diagnosis and treatment. The project is funded by the VPP (National Research Program). Project no. VPP-COVID-2020 / 1-0023.
Duration: 01/07/2020 - 31/12/2020 (extended until 31/03/2021)
Identification No.: VPP-COVID-2020/1-0023
Total funding: 497 580,00 EUR (UL ICPM input 49 980, 00 EUR)
Project leader: Rīgas Stradiņa universitāte
UL ICPM responibility: work package 8
Aim: Based on the analysis of the situation in Latvia, to develop a practical approach to public health and medical measures aimed at reducing the mortality caused by gastric cancer and the related negative effects of risk factors and pre-cancer condition.
Duration: 01/01/2017 - 31/12/2017
Program manager: Dr.med. Valdis Pīrāgs
Scientific manager: Dr.med. Mārcis Leja
The Latvian Council of Science
LZP - The Latvian Council of Science was established in 1991. In accordance with the Law on Scientific Activity, the Latvian Council of Science is a collegiate institution of the scientists under the supervision of the Ministry of Education and Science. The Council is a counsellor of the Latvian Government on research and researchers training issues. It advises on the formulation and implementation of science, higher education and R&D policy. The Council takes active part in project based competitive R&D funding, as well as promotes the development of Latvian researcher resources and fosters the international scientific cooperation.
Aim: To reduce the mortality caused by gastric cancer by eradicating H. pylori and determining pepsinogen levels. Project is funded by FLPP (Fundamental and Applied Research Projects) Program. Program is implemented by Latvian Council of Science, project No. lzp-2018/1-0135.
Duration: 31/08/2018 - 31/08/2021
Identification No.: lzp-2018/1-0135
Total funding: 300 000 EUR
Scientific manager: Dr. med. Mārcis Leja
More information on project website
Aim: To contribute to ethically and socially responsible governance of research biobanks in Latvia by analysing opinions of the general public, donors and researchers. The work is funded by FLPP (Fundamental and Applied Research Projects) Program. Program is implemented by Latvian Council of Science, project No. lzp-2018/2-0171.
Duration: 01/12/2018 - 30/11/2020
Identification No.: lzp-2018/2-01710
Total funding: 200 000 EUR
Scientific manager: Asoc. prof. Signe Mežinska
The work is funded by FLPP (Fundamental and Applied Research Projects) Program. Program is implemented by Latvian Council of Science, project No. lzp-2018/2-0228.
Duration: 01/12/2018 - 30/11/2020
Identification No.: LZP2018/29
Total funding: 200 000 EUR
Scientific manager: Ilze Kikuste
Duration: 01/03/2013 - 31/12/2016
Scientific manager: Dr.med. Mārcis Leja
OTHER
The research group of the Institute of Clinical and Preventive Medicine, consisting of Līva Anspuka, Ilze Birka, Lelde Cīrule-Dambe, and Liene Sondore, Dr. med., under the supervision of dietitian Daiga Šantare, has created a booklet that adapts practical recommendations for the Nordic diet to the conditions in Latvia. Alongside the Mediterranean diet, the World Health Organization recommends this type of diet as a healthy, balanced diet for the prevention of non-communicable diseases. The booklet includes several sections - an overview of products, recommendations for food preparation, as well as sample menus.